Imaging CRO. Introducing Invicro's imaging technology in the United States. Supports from preclinical studies to late phase clinical trial. In particular, Invicro has strengths in quantitative analysis in the central nervous system area. In addition, Quanticell 🄬, a fluorescent tissue stain developed by Konica Minolta, is more sensitive and quantitative than conventional immunohistochemistry (IHC). We provide quantitative analysis in combination with intracellular distribution and intracellular localization information of target molecules such as proteins and drugs.